Medical device company Ceragenix Pharmaceuticals has entered into an exclusive distribution and supply agreement with Megapharm Ltd., an Israeli company, to commercialise EpiCeram.
(Aug 5, 2009)
WELCOME TO MDDEXEC.com
Thank you for visiting our new community of Medical Device & Diagnostics sales & marketing executives. If it's your first time, click one of these links to learn more.
Companies accused of marketing their products for unapproved uses
Medical device firms like Boston Scientific, St. Jude Medical, Medtronic and three smaller companies have been accused of offering illegal kickbacks to encourage doctors to use their medical devices for unapproved uses.
(Aug 5, 2009)Endoscopic Technologies to pay $1.4m to settle fraud
Medical device manufacturer Endoscopic will pay $1.4 million to settle Medicare fraud claims related to surgical ablation devices used in heart surgery.
(Aug 5, 2009)Ceragenix makes progress with Cerashield antimicrobial technology
Ceragenix Pharmaceuticals has entered into an exclusive evaluation and option to license agreement with a healthcare company covering the use of the company’s Cerashield antimicrobial technology for a specific medical device associated with a high incidence of hospital acquired infection
(May 29, 2009)Winner Medical sets up JV in China
Winner Medical Group Inc. and Chengdu Likang Industries have set up a joint venture in Chengdu to pursue medical dressing product markets opportunities in West China.
The JV has been established through Winner Medical’s wholly-owned subsidiary, Winner Industries (Shenzhen) Co., Ltd.
(May 29, 2009)Rafael Medical receives marketing clearance
Rafael Medical Technologies Ltd. has obtained marketing clearance from the U.S. Food and Drug Administration (FDA) for its SafeFlo Vena Cava Filter.
The approval is for the permanent implantation of the filter in patients at risk of pulmonary embolism; safety and effectiveness as a retrievable or temporary filter have not been established.
(May 29, 2009)Boston Scientific gets EU approval for its new offering
Boston Scientific Inc. has said that European Union regulators have approved a new system of wires used in implanted heart devices.
The company said its Endotak Reliance 4-site system has received marketing approval.
(May 29, 2009)CerviLenz raises $4m
CerviLenz Inc. has raised $4 million in the company’s initial round of venture funding. The company is a maker of a disposable device used to predict the risk of preterm birth in pregnant women.
Louisville-based Chrysalis Ventures invested in CerviLenz along with Ann Arbor, Mich.-based Arboretum Ventures.
(May 29, 2009)Making “relationship” marketing more transparent
In a crucial move, which has been described as the most stringent state effort to regulate the marketing of medical products to doctors, the Vermont legislature has passed a law requiring drug and device makers to publicly disclose all money given to physicians and other health care providers, naming names and listing dollar amounts.
(May 29, 2009)Launching New Products: Five Deadly Sins
After all the market assessments and business plans, many new products still fail to achieve commercial success. Why do so many new products fail?
